Tokyo, June 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061824) titled 'Elucidation of the Effects of Antidiabetic Drugs on the Progression of Diabetic Nephropathy via the Bacteria-Derived Peptide Corisin' on June 8.
Study Type:
Observational
Primary Sponsor:
Institute - Mie University
Condition:
Condition - diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In this study, we will investigate whether administration of the target drugs (metformin, SGLT2 inhibitors, GLP-1 receptor agonists, and GLP-1/GIP receptor agonists) alters the systemic levels of the microbiota-derived peptide corisin and examine its association with...